Cargando…

mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) is an aggressive disease that exhibits constitutive activation of phosphoinositide 3-kinase (PI3K) driven by chronic B-cell receptor signaling or PTEN deficiency. Since pan-PI3K inhibitors cause severe side effects, we investigated the anti-lymphoma efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Wendan, Berning, Philipp, Erdmann, Tabea, Grau, Michael, Bettazová, Nardjas, Zapukhlyak, Myroslav, Frontzek, Fabian, Kosnopfel, Corinna, Lenz, Peter, Grondine, Michael, Willis, Brandon, Lynch, James T., Klener, Pavel, Hailfinger, Stephan, Barry, Simon T., Lenz, Georg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883168/ https://www.ncbi.nlm.nih.gov/pubmed/36352190 http://dx.doi.org/10.1038/s41375-022-01749-0

Ejemplares similares

Molecular profiling of EBV associated diffuse large B-cell lymphoma
por: Frontzek, Fabian, et al.
Publicado: (2023)

Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma
por: Patra-Kneuer, Maria, et al.
Publicado: (2023)

P1227: COMPREHENSIVE MOLECULAR SUBTYPING OF DIFFUSE LARGE B-CELL LYMPHOMA CELL LINES AND ASSOCIATION WITH TAFASITAMAB ACTIVITY
por: Arora, Arshi, et al.
Publicado: (2023)

Combination Treatment Targeting mTOR and MAPK Pathways Has Synergistic Activity in Multiple Myeloma
por: Sun, Kaiyan, et al.
Publicado: (2023)

Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma
por: Frontzek, Fabian, et al.
Publicado: (2021)

Epigenetic Regulation of Circadian Rhythm and Its Possible Role in Diabetes Mellitus
por: Hudec, Michael, et al.
Publicado: (2020)

Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age
por: Burkhardt, Birgit, et al.
Publicado: (2022)

Current options and future perspectives in the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma
por: Frontzek, Fabian, et al.
Publicado: (2022)

Drug Resistance in Non-Hodgkin Lymphomas
por: Klener, Pavel, et al.
Publicado: (2020)

Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms
por: Kalmbach, Sabrina, et al.
Publicado: (2023)

Advances in Molecular Biology and Targeted Therapy of Mantle Cell Lymphoma
por: Klener, Pavel
Publicado: (2019)

Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma
por: Heming, Michael, et al.
Publicado: (2022)

Current Immunotherapy Approaches in Non-Hodgkin Lymphomas
por: Pytlik, Robert, et al.
Publicado: (2020)

BCL-2 Proteins in Pathogenesis and Therapy of B-Cell Non-Hodgkin Lymphomas
por: Klanova, Magdalena, et al.
Publicado: (2020)

Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas
por: Bognar, M K, et al.
Publicado: (2016)

Human melanoma cells resistant to MAPK inhibitors can be effectively targeted by inhibition of the p90 ribosomal S6 kinase
por: Kosnopfel, Corinna, et al.
Publicado: (2017)

Novel therapeutic targets in diffuse large B-cell lymphoma
por: Lenz, Georg
Publicado: (2013)

Targeted Drug Delivery and Theranostic Strategies in Malignant Lymphomas
por: Etrych, Tomas, et al.
Publicado: (2022)

Diffuse Large B-Cell Lymphoma (DLBCL): Early Patient Management and Emerging Treatment Options
por: Vodicka, Prokop, et al.
Publicado: (2022)

Lymphocyte access to lymphoma is impaired by high endothelial venule regression
por: Menzel, Lutz, et al.
Publicado: (2021)

Retrospective Analysis of 118 Patients With Cutaneous T-Cell Lymphomas: A Single-Center Experience
por: Polgárová, Kamila, et al.
Publicado: (2022)

PI3K/AKT addiction in subsets of diffuse large B-cell lymphoma
por: Pfeifer, Matthias, et al.
Publicado: (2013)

Crizotinib in Combination with Everolimus Synergistically Inhibits Proliferation of Anaplastic Lymphoma Kinase‒Positive Anaplastic Large Cell Lymphoma
por: Xu, Wendan, et al.
Publicado: (2018)

Nasal NK/T cell lymphoma presents with long-term nasal blockage and fever: a rare case report and literature review
por: Zou, Hai, et al.
Publicado: (2016)

Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation
por: Li, Licen, et al.
Publicado: (2021)

Can morphological MRI differentiate between primary central nervous system lymphoma and glioblastoma?
por: Malikova, H., et al.
Publicado: (2016)

Investigation of potential traces of pluripotency in germinal-center-derived B-cell lymphomas driven by MYC
por: Wagener, R, et al.
Publicado: (2015)

Insights into the Molecular Pathogenesis of Activated B-Cell-like Diffuse Large B-Cell Lymphoma and Its Therapeutic Implications
por: Lenz, Georg
Publicado: (2015)

The role of autologous stem cell transplantation (ASCT) in aggressive B-cell lymphomas: real-world data from a retrospective single-center analysis
por: Wullenkord, Ramona, et al.
Publicado: (2021)

Addendum: Nasal NK/T cell lymphoma presents with long-term nasal blockage and fever: a rare case report and literature review
por: Zou, Hai, et al.
Publicado: (2023)

Dissection of gene expression datasets into clinically relevant interaction signatures via high-dimensional correlation maximization
por: Grau, Michael, et al.
Publicado: (2019)

Transcriptional reprogramming by mutated IRF4 in lymphoma
por: Schleussner, Nikolai, et al.
Publicado: (2023)

Fatal Cutaneous γ/δ T-Cell Lymphoma with Central Nerve System Metastasis
por: Youn, Sung Hwan, et al.
Publicado: (2011)

PI3Kδ Inhibitors as Immunomodulatory Agents for the Treatment of Lymphoma Patients
por: Tarantelli, Chiara, et al.
Publicado: (2021)

Differential expression, localization and activity of MARCKS between mantle cell lymphoma and chronic lymphocytic leukemia
por: Vargova, J, et al.
Publicado: (2016)

CK1δ in lymphoma: gene expression and mutation analyses and validation of CK1δ kinase activity for therapeutic application
por: Winkler, B. Sophia, et al.
Publicado: (2015)

Phosphatidylinositol 3-kinase-δ (PI3K-δ) is a potential therapeutic target in adult T-cell leukemia-lymphoma
por: Katsuya, Hiroo, et al.
Publicado: (2018)

Anti-Lymphoma Efficacy Comparison of Anti-CD20 Monoclonal Antibody-Targeted and Non-Targeted Star-Shaped Polymer-Prodrug Conjugates
por: Lidický, Ondřej, et al.
Publicado: (2015)

Occurrence of B-cell lymphomas in patients with Activated Phosphoinositide 3-Kinase δ syndrome
por: Kracker, Sven, et al.
Publicado: (2014)

Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysis
por: Thieblemont, Catherine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i6it25i4hlis8vhodfii66ihho